Edwards Lifesciences Corp (EW)
Return on equity (ROE)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 1,402,400 | 1,521,900 | 1,503,100 | 823,400 | 1,046,900 |
| Total stockholders’ equity | US$ in thousands | 6,650,000 | 5,806,700 | 5,835,900 | 4,574,300 | 4,148,300 |
| ROE | 21.09% | 26.21% | 25.76% | 18.00% | 25.24% |
December 31, 2023 calculation
ROE = Net income ÷ Total stockholders’ equity
= $1,402,400K ÷ $6,650,000K
= 21.09%
The return on equity (ROE) of Edwards Lifesciences Corp has shown fluctuations over the past five years, ranging from 18.00% in 2020 to 26.21% in 2022. In the most recent year, as of December 31, 2023, the ROE stands at 21.09%.
The ROE measures the company's profitability by showing how effectively it generates profits from shareholders' equity. A higher ROE indicates better efficiency in utilizing equity to generate profits for shareholders.
While the ROE of Edwards Lifesciences Corp has slightly decreased from the previous year, it remains at a relatively healthy level, reflecting the company's ability to generate profits from the equity invested by shareholders. However, investors and analysts may want to further investigate the factors contributing to this change in ROE and assess the company's overall financial health and performance.
Peer comparison
Dec 31, 2023